Form 4: ICU Medical Director Executes Stock Option Exercise

Director David C. Greenberg exercised stock options and sold shares of ICU Medical, Inc. (ICUI) in a series of transactions.

Summary

• Director David C. Greenberg exercised options for 2,424 shares of common stock at a price of $101.06 per share on May 12, 2026.
• On the same day, the director sold 2,424 shares at a price of $122.91 per share.
• On May 13, 2026, the director acquired 1,254 shares via the vesting of Restricted Stock Units (RSUs) at zero cost.
• Following these transactions, the director holds 9,214 shares of common stock directly.
• A new grant of 1,475 RSUs was awarded to the director on May 13, 2026, vesting on May 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions appear to be routine equity compensation management by a director.

Positives

• Director maintains a direct ownership stake of 9,214 shares, indicating continued alignment with shareholder interests.

Negatives

• The sale of 2,424 shares at $122.91 represents a liquidation of the exercised options rather than a long-term hold of the underlying equity.

Risks

• None identified in this filing.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity transactions.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as option exercises and subsequent sales, are standard corporate governance practices and generally do not signal a change in company strategy or fundamental health.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for Section 16 insiders.
• The use of Rule 10b5-1 plans or standard vesting schedules is consistent with industry practices for public company directors.

Stakeholder Impact

• Minimal impact on shareholders as these are standard insider equity movements.

Next Steps

• Vesting of 1,475 RSUs on May 13, 2027.

Key Dates

Keywords

ICU Medical, ICUI, Form 4, Insider Trading, Stock Options, Director Transactions